KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) EBT Margin (2016 - 2026)

Medtronic (MDT) has disclosed EBT Margin for 13 consecutive years, with 15.57% as the latest value for Q1 2026.

  • Quarterly EBT Margin fell 300.0% to 15.57% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 15.68% through Jan 2026, down 5.0% year-over-year, with the annual reading at 16.78% for FY2025, 184.0% up from the prior year.
  • EBT Margin hit 15.57% in Q1 2026 for Medtronic, down from 17.82% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 20.47% in Q1 2022 to a low of 9.95% in Q2 2024.
  • Historically, EBT Margin has averaged 16.75% across 5 years, with a median of 17.79% in 2023.
  • Biggest five-year swings in EBT Margin: surged 478bps in 2022 and later crashed -820bps in 2024.
  • Year by year, EBT Margin stood at 18.39% in 2022, then decreased by -11bps to 16.45% in 2023, then rose by 13bps to 18.55% in 2024, then dropped by -4bps to 17.82% in 2025, then decreased by -13bps to 15.57% in 2026.
  • Business Quant data shows EBT Margin for MDT at 15.57% in Q1 2026, 17.82% in Q4 2025, and 15.18% in Q3 2025.